Resolutions for the General Meeting of Shareholders
Extraordinary general meeting of shareholdersPartial Amendment to the Articles of Incorporation
Shareholder ProposalMatter concerning the dismissal of Director Watanabe Shuichi (渡辺秀一)
Matter concerning the distribution of surplus (special dividend)
Acquisition of treasury shares
A proposal has been submitted by a shareholder. Proposal 1 comprises both a company proposal and a shareholder proposal, while Proposals 2 through 4 are shareholder proposals. The Board of Directors opposes Proposals 2 through 4.
A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.| Item | Details |
|---|---|
| Type of shareholders' meeting | Extraordinary general meeting of shareholders |
| Date and time | 10:00 a.m., 15 December 2026 (Tuesday) |
| Matters for resolution | Proposal No. 1: Partial Amendment to the Articles of Incorporation, Proposal No. 2: Matter concerning the dismissal of Director Watanabe Shuichi (渡辺秀一), Proposal No. 3: Matter concerning the distribution of surplus (special dividend), Proposal 4: Acquisition of treasury shares |
| Shareholder Proposal | A proposal has been submitted by a shareholder. Proposal 1 comprises both a company proposal and a shareholder proposal, while Proposals 2 through 4 are shareholder proposals. The Board of Directors opposes Proposals 2 through 4. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.An extraordinary general meeting of shareholders will be held at the request of shareholders. The Board of Directors opposes the shareholder proposals on the grounds of compatibility with growth investment, financial soundness, the stable supply of pharmaceuticals and other products, and the common interests of shareholders.